|
INDIA BUSINESS WORLD - 1st March - TO - 15th March - 2009
FDA NOD FOR RANBAXY’S CARDIOVASCULAR DRUG
Ranbaxy Laboratories has received the final approval from the US Food and Drug Administration's (USFDA) to sell Ramipril capsules (in 5mg & 10mg), a drug used to treat cardiovascular diseases. The application for the drug was submitted by Ranbaxy from Ohm Laboratories (New Jersey), USA, its subsidiary. "The office of generic drugs, USFDA, had determined the Ranbaxy formulations to be bioequivalent and having the same therapeutic effect as the original drug, Altace, made by King Pharmaceuticals Inc, "a Ranbaxy release said. This is the third marketing approval from Ohm Laboratories in the last two months. Ramipril is the generic version of Altace
|
